On September 2, 2021 Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company discovering and developing breakthrough treatments for immune-mediated and oncologic disorders, reported members of the executive team will participate in the following upcoming virtual investor conferences (Press release, Kezar Life Sciences, SEP 2, 2021, View Source [SID1234587190]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Wells Fargo Virtual Healthcare Conference
Thursday, September 9, 2021, 4:00 PM ET
Presenter: John Fowler, Chief Executive Officer, and Noreen Roth Henig, M.D., Chief Medical Officer

H. C. Wainwright 23rd Annual Global Investment Conference
Monday, September 13, 2021, 7:00 AM ET
Presenter: John Fowler, Chief Executive Officer

A webcast of both presentations may be accessed at the "Events & Presentations" section of Kezar’s website at View Source Kezar Life Sciences will maintain an archived replay of the webcasts on its website for 90 days after the conferences.